LFCR
Price
$8.04
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
176.87M
51 days until earnings call
NBIX
Price
$129.11
Change
-$0.29 (-0.22%)
Updated
Jul 3 closing price
Capitalization
13.72B
29 days until earnings call
Interact to see
Advertisement

LFCR vs NBIX

Header iconLFCR vs NBIX Comparison
Open Charts LFCR vs NBIXBanner chart's image
Lifecore Biomedical
Price$8.04
Change-$0.00 (-0.00%)
Volume$55.72K
Capitalization176.87M
Neurocrine Biosciences
Price$129.11
Change-$0.29 (-0.22%)
Volume$387.39K
Capitalization13.72B
LFCR vs NBIX Comparison Chart in %
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. NBIX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and NBIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (LFCR: $8.04 vs. NBIX: $129.11)
Brand notoriety: LFCR and NBIX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 23% vs. NBIX: 32%
Market capitalization -- LFCR: $176.87M vs. NBIX: $13.72B
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. NBIX’s [@Pharmaceuticals: Other] market capitalization is $13.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • NBIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NBIX is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 3 TA indicator(s) are bullish while NBIX’s TA Score has 3 bullish TA indicator(s).

  • LFCR’s TA Score: 3 bullish, 4 bearish.
  • NBIX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than NBIX.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а -2.31% price change this week, while NBIX (@Pharmaceuticals: Other) price change was +1.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

LFCR is expected to report earnings on Aug 27, 2025.

NBIX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than LFCR($177M). LFCR YTD gains are higher at: 8.210 vs. NBIX (-5.414). NBIX has higher annual earnings (EBITDA): 358M vs. LFCR (-22.64M). NBIX has more cash in the bank: 1.03B vs. LFCR (4.22M). LFCR has less debt than NBIX: LFCR (157M) vs NBIX (428M). NBIX has higher revenues than LFCR: NBIX (1.89B) vs LFCR (188M).
LFCRNBIXLFCR / NBIX
Capitalization177M13.7B1%
EBITDA-22.64M358M-6%
Gain YTD8.210-5.414-152%
P/E RatioN/A57.20-
Revenue188M1.89B10%
Total Cash4.22M1.03B0%
Total Debt157M428M37%
FUNDAMENTALS RATINGS
LFCR vs NBIX: Fundamental Ratings
LFCR
NBIX
OUTLOOK RATING
1..100
5071
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
10060
PRICE GROWTH RATING
1..100
3950
P/E GROWTH RATING
1..100
537
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBIX's Valuation (72) in the Biotechnology industry is in the same range as LFCR (93) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

NBIX's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that NBIX’s stock grew similarly to LFCR’s over the last 12 months.

NBIX's SMR Rating (60) in the Biotechnology industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that NBIX’s stock grew somewhat faster than LFCR’s over the last 12 months.

LFCR's Price Growth Rating (39) in the Industrial Specialties industry is in the same range as NBIX (50) in the Biotechnology industry. This means that LFCR’s stock grew similarly to NBIX’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is in the same range as NBIX (37) in the Biotechnology industry. This means that LFCR’s stock grew similarly to NBIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRNBIX
RSI
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 4 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
53%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 5 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 10 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCU57.121.49
+2.68%
Invesco S&P SmallCap Ult & Comnc Svc ETF
QIS22.620.41
+1.85%
Simplify Multi-QIS Alternative ETF
VFMF137.291.09
+0.80%
Vanguard US Multifactor ETF
JMEE60.990.47
+0.78%
JPMorgan Small & Mid Cap Enh Eq ETF
KTN26.21-0.02
-0.08%
Structured Products CorTS Aon Capital A

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and NBIX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and NBIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
N/A
NBIX - LFCR
32%
Poorly correlated
-0.22%
SHPH - LFCR
31%
Poorly correlated
-1.51%
AMRX - LFCR
28%
Poorly correlated
+0.60%
ALKS - LFCR
28%
Poorly correlated
-0.52%
HROW - LFCR
27%
Poorly correlated
+3.86%
More

NBIX and

Correlation & Price change

A.I.dvisor tells us that NBIX and LFCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
-0.22%
LFCR - NBIX
32%
Poorly correlated
N/A
ELAN - NBIX
30%
Poorly correlated
-0.54%
EOLS - NBIX
29%
Poorly correlated
+0.65%
CGC - NBIX
29%
Poorly correlated
+7.56%
TLRY - NBIX
26%
Poorly correlated
+11.03%
More